Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol 4,5-bisphosphate 3-kinase beta (PI3Kβ) is an isoform of the class IA phosphoinositide 3-kinases (PI3Ks), a family of lipid kinases that play central roles in cellular signaling. PI3Kβ specifically catalyzes the phosphorylation of phosphatidylinositol-4,5-bisphosphate (PIP2) to generate phosphatidylinositol-3,4,5-trisphosphate (PIP3), a second messenger that regulates diverse cellular processes including growth, proliferation, survival, metabolism, and motility. It is a heterodimer composed of a regulatory subunit (often p85α or its variants) and a catalytic subunit (p110β). PI3Kβ has both kinase-dependent and kinase-independent functions, most notably in DNA replication and cell cycle progression in addition to its role in canonical PI3K/AKT/mTOR signaling.
Inhibition of PI3Kβ activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol 4,5-bisphosphate 3-kinase beta (PI3Kβ).